Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
8.526 USD | -7.93% | -7.54% | +132.92% |
03:13pm | Oppenheimer Adjusts Mind Medicine Price Target to $20 From $29, Maintains Outperform Rating | MT |
05-08 | Transcript : Mind Medicine Inc., Q1 2024 Earnings Call, May 08, 2024 |